Frequency Therapeutics · Regenerative Medicine · Phase 2
DiscontinuedTherapeutic
Evidence
company
Confidence
96%
Indications
Hearing LossSensorineural Hearing LossNoise-Induced Hearing LossSudden Sensorineural Hearing Loss
Population
Adult
Start with a treatment, device, company, diagnosis, or trial ID. Each record keeps the source trail close to the claim.